Nivolumab (opdivo) presentation at EHA | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  587 of 600  at  6/16/2019 5:48:11 AM  by

Biotech2050


Nivolumab (opdivo) presentation at EHA

 
 #EHA24 #lymsm Impressive results of #Nivolumab + #brentuximab for R/R #PMBCL #lymphoma: ORR 70%, CR 43%
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 196
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...